A nurse at work at Jakarta’s Persahabatan Hospital, the Indonesia’s leading TB center. The country has the world’s highest burden of tuberculosis after India, and is also home to a large number of drug-resistant TB patients. The Global Fund is investing heavily in the expansion of molecular diagnostic technology, which delivers faster, more accurate results and can detect TB and drug resistance within two hours.